Pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, accounts for more than 90% of pancreatic tumors. While the 5-year survival rate for PDAC has increased over the […]
An Overview of Pancreatic Cysts
For many people, a pancreatic cyst is a scary diagnosis, but these cysts are surprisingly common. It is important to remember that most pancreatic cysts are not cancerous and will […]
Endoscopic Techniques for the Diagnosis and Management of Pancreatic Cysts and Tumors
At the 20th Annual Symposium on Pancreatic Cancer, V. Raman Muthusamy, MD, MAS, a Professor of Clinical Medicine at the David Geffen School of Medicine and the Medical Director of […]
Treatment and Prevention of Pancreatic Cancer with Cancer Vaccines
Over the past year, there have been promising results from multiple early stage clinical trials evaluating cancer vaccines, one type of immunotherapy, in pancreatic cancer patients. From the AMPLIFY-201 trial […]
Targeting immune suppression to treat pancreatic cancer
While immunotherapy has transformed the clinical landscape for various solid malignancies, most notably melanoma and lung cancer, pancreatic ductal adenocarcinoma (PDAC) remains exceptionally recalcitrant to these T-cell-activating modalities. This profound […]
Overcoming immunotherapy resistance in pancreatic cancer
Immunotherapy, a type of treatment aimed at engaging the immune system – namely, T cells – to attack and kill cancer cells, has had success and redefined care in multiple […]